Terms: = Head and neck cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
75 results:
1. Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.
Koeck S; Amann A; Kern J; Zwierzina M; Lorenz E; Sopper S; Zwierzina H; Mildner F; Sykora M; Sprung S; Hackl H; Augustin F; Maier HT; Pircher A; Pall G; Wolf D; Gamerith G
Oncoimmunology; 2023; 12(1):2274130. PubMed ID: 38126028
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. A novel m7G regulator-based methylation patterns in head and neck squamous cell carcinoma.
Ying Y; Zhang W; Zhu H; Luo J; Xu X; Yang S; Zhao Y; Zhang Z
Mol Carcinog; 2023 Dec; 62(12):1902-1917. PubMed ID: 37642290
[TBL] [Abstract] [Full Text] [Related]
4. Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
Hue J; Valinciute Z; Thavaraj S; Veschini L
Oral Oncol; 2023 Jun; 141():106399. PubMed ID: 37098302
[TBL] [Abstract] [Full Text] [Related]
5. A survival prediction model via interpretable machine learning for patients with oropharyngeal cancer following radiotherapy.
Pan X; Feng T; Liu C; Savjani RR; Chin RK; Sharon Qi X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6813-6825. PubMed ID: 36807760
[TBL] [Abstract] [Full Text] [Related]
6. MYCBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients.
Wang G; Miao C; Mo L; Kahlert UD; Wu J; Ou M; Huang R; Feng R; Pang W; Shi W
Front Immunol; 2022; 13():1048503. PubMed ID: 36582246
[TBL] [Abstract] [Full Text] [Related]
7. Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma.
Liu Z; Tian Y; Zhang X; Wang J; Yang J
Cancer Gene Ther; 2023 May; 30(5):659-670. PubMed ID: 36380145
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.
Gu P; Zeng Y; Ma W; Zhang W; Liu Y; Guo F; Ruan X; Chi J; Zheng X; Gao M
Front Endocrinol (Lausanne); 2022; 13():1008301. PubMed ID: 36353231
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of DOCK6 in oral squamous cell cancer promotes cellular migration and invasion and is associated with poor prognosis.
Zhang ZY; Sun YY; Wang HC; Fu WN; Sun CF
Arch Oral Biol; 2022 Jan; 133():105297. PubMed ID: 34742001
[TBL] [Abstract] [Full Text] [Related]
10. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical detection of "ex novo" HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients.
Prampolini C; Almadori G; Bonvissuto D; Barba M; Giraldi L; Boccia S; Paludetti G; Galli J; Parolini O; Settimi S; Cadoni G
HLA; 2021 Dec; 98(6):517-524. PubMed ID: 34605215
[TBL] [Abstract] [Full Text] [Related]
12. Cutoff Age Between Pediatric and Adult Thyroid Differentiated cancer: Is 18 Years Old Appropriate?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Yoshioka K; Ito K
Thyroid; 2022 Feb; 32(2):145-152. PubMed ID: 34549602
[No Abstract] [Full Text] [Related]
13. Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Li X; Liu Z; Zhou W; Liu X; Cao W
BMC Cancer; 2021 Aug; 21(1):922. PubMed ID: 34391381
[TBL] [Abstract] [Full Text] [Related]
14. Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.
Sathasivam HP; Kist R; Sloan P; Thomson P; Nugent M; Alexander J; Haider S; Robinson M
Br J Cancer; 2021 Aug; 125(3):413-421. PubMed ID: 33972745
[TBL] [Abstract] [Full Text] [Related]
15. Histopathological Factors in Oral Squamous Cell Carcinoma-Should a Clinician Look Beyond clinical Staging?
Sethi S; Ohri S; Aggarwal P; Grewal H
J Oral Maxillofac Surg; 2021 Aug; 79(8):1694-1705. PubMed ID: 33744240
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.
Lin B; Li H; Zhang T; Ye X; Yang H; Shen Y
Aging (Albany NY); 2021 Feb; 13(4):5718-5747. PubMed ID: 33592580
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract] [Full Text] [Related]
18. clinical outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma.
Dai W; Chung DL; Chow LK; Yu VZ; Lei LC; Leong MM; Chan CK; Ko JM; Lung ML
Clin Cancer Res; 2020 Dec; 26(24):6494-6504. PubMed ID: 32988965
[TBL] [Abstract] [Full Text] [Related]
19. Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.
Shodo R; Yamazaki K; Ueki Y; Takahashi T; Horii A
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):2001-2009. PubMed ID: 32772234
[TBL] [Abstract] [Full Text] [Related]
20. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract] [Full Text] [Related]
[Next]
